These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Antibodies to the herpes simplex virus type-2-induced tumor-associated antigen AG-4 as markers of recurrence in cervical cancer.
    Author: te Velde ER, Aurelian L.
    Journal: Tumour Biol; 1987; 8(1):26-33. PubMed ID: 3037680.
    Abstract:
    This study was designed to evaluate the potential clinical value of AG-4 antibodies in patients with established cervical cancer, in terms of the assessment of prognosis before treatment, and monitoring the course of the cancer process during long-term follow-up. Forty-seven patients were investigated during a median follow-up time of 5.4 years (range 3.5-6.2). During this time, 25 developed recurrent disease. Serum was obtained from all patients before treatment and at regular intervals during follow-up and assayed for antibodies to AG-4. The presence of AG-4 antibodies during follow-up was associated with recurrent disease (p less than 0.001). In most cases the presence of AG-4 antibodies preceded the clinical diagnosis of recurrence, with particularly long lead times in the late recurrences. Serial determinations of AG-4 antibodies in patients with invasive cervical cancer may be of clinical value for monitoring the course of the disease during follow-up, thus allowing for earlier application of treatment.
    [Abstract] [Full Text] [Related] [New Search]